CIXUTUMUMAB

Search structure

Action	Mechanism of Action	Reference
ANTAGONIST	Insulin-like growth factor I receptor antagonist	PMC

Mesh Heading	Maximum Phase	Mesh ID	Reference
Colonic Neoplasms	2	D003110	ClinicalTrials
Carcinoma, Hepatocellular	2	D006528	ClinicalTrials
Breast Neoplasms	2	D001943	ClinicalTrials
Breast Neoplasms	2	D001943	ClinicalTrials
Prostatic Neoplasms, Castration-Resistant	2	D064129	ClinicalTrials
Lung Neoplasms	2	D008175	ClinicalTrials
Prostatic Neoplasms	2	D011471	ClinicalTrials
Carcinoma, Squamous Cell	2	D002294	ClinicalTrials
Mesothelioma	2	D008654	ClinicalTrials
Melanoma	2	D008545	ClinicalTrials
Rhabdomyosarcoma, Alveolar	2	D018232	ClinicalTrials
Rhabdomyosarcoma, Embryonal	2	D018233	ClinicalTrials
Osteosarcoma	2	D012516	ClinicalTrials
Small Cell Lung Carcinoma	2	D055752	ClinicalTrials
Carcinoma, Large Cell	2	D018287	ClinicalTrials
Carcinoma, Non-Small-Cell Lung	2	D002289	ClinicalTrials
Head and Neck Neoplasms	2	D006258	ClinicalTrials
Colorectal Neoplasms	2	D015179	ClinicalTrials
Adenocarcinoma of Lung	2	D000077192	ClinicalTrials
Adrenal Cortex Neoplasms	2	D000306	ClinicalTrials
Rectal Neoplasms	2	D012004	ClinicalTrials
Sarcoma	2	D012509	ClinicalTrials
Neoplasms	1	D009369	ClinicalTrials
Pancreatic Neoplasms	1	D010190	ClinicalTrials
Neoplasms	1	D009369	ClinicalTrials
Breast Neoplasms, Male	1	D018567	ClinicalTrials

CONTENTS


Active Pharmaceutical Ingredients (APIs) Scaffolds	Exact Similarity SubStructure	Threshold (%) >= 70